Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD
Recruiting · NCT06449833 · Registry updated 2024-06-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Effect of Henagliflozein on Hepatic Fat Content in Patients With T2DM and NAFLD | Digestive System Diseases, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, fatty liver disease, glucose metabolism disease, liver disorder, metabolic disease, metabolic dysfunction-associated steatotic liver disease, type 2 diabetes mellitus | Recruiting | Phase 4 | 2024-06-10 | NCT06449833 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Zhujiang Hospital | 82 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Zhujiang Hospital of Southern Medical University | Guangzhou | China | 17 |